TABLE 3.

Descriptive Statistics for the Health Outcomes at Each Assessment

Outcome	All (N = 250)	ABC (n = 84)	AMF (n = 83)	UC (n = 83)
Asthma symptoms per month, mean ± SD
0 mo of follow-up	6.39 ± 6.84	7.38 ± 7.00	6.38 ± 6.89	5.41 ± 6.56
6 mo of follow-up	4.59 ± 5.63	4.09 ± 5.14	5.09 ± 6.41	4.61 ± 5.35
12 mo of follow-up	4.58 ± 5.96	3.75 ± 4.64	5.50 ± 6.97	4.47 ± 5.95
18 mo of follow-up	4.53 ± 6.32	3.36 ± 4.67	5.98 ± 7.83	4.35 ± 5.95
ED visits In previous 6 mo, mean ± SD
0 mo of follow-up	2.84 ± 3.10	2.63 ± 2.99	3.10 ± 3.00	2.81 ± 3.32
6 mo of follow-up	1.35 ± 1.88	1.19 ± 1.31	1.72 ± 2.48	1.16 ± 1.68
12 mo of follow-up	1.11 ± 1.77	0.86 ± 1.38	1.11 ± 1.77	1.35 ± 2.08
18 mo of follow-up	0.88 ± 1.39	0.81 ± 1.04)	0.74 ± 1.25)	1.10 ± 1.78
Hospitalization In previous 6 mo, n (%)
0 mo of follow-up	104 (41.6)	35 (41.7)	35 (42.2)	34 (41.0)
6 mo of follow-up	46 (20.4)	13 (16.9)	19 (26.4)	14 (18.4)
12 mo of follow-up	41 (18.3)	10 (13.9)	16 (21.3)	15 (19.5)
18 mo of follow-up	34 (14.5)	12 (14.8)	12 (15.8)	10 (13.0)
Courses of oral steroids in previous 6 mo, mean ± SD
0 mo of follow-up	2.41 ± 2.48	2.60 ± 3.15	2.20 ± 1.81	2.43 ± 2.29
6 mo of follow-up	1.21 ± 1.63	0.94 ± 1.08	1.40 ± 1.90	1.32 ± 1.79
12 mo of follow-up	1.08 ± 1.55	0.81 ± 1.02	1.13 ± 1.66	1.27 ± 1.81
18 mo of follow-up	1.09 ± 2.31	0.74 ± 0.91	0.96 ± 1.59	1.57 ± 3.56